CC BY-NC-ND 4.0 · Journal of Digestive Endoscopy 2019; 10(02): 097-100
DOI: 10.1055/s-0039-1693538
Review Article
Society of Gastrointestinal Endoscopy of India

Sedation and Anesthesia in Gastrointestinal Endoscopy: Indian Scenario

Apurva Shah
1   Medical Gastroenterology, Apollo Hospitals International Limited, Ahmedabad, India
,
Shravan Bohra
1   Medical Gastroenterology, Apollo Hospitals International Limited, Ahmedabad, India
,
Megha Shah
2   Community Health Centre, Mehmedabad, Kheda, Gujarat, India
› Author Affiliations
Further Information

Publication History

Publication Date:
07 August 2019 (online)

Abstract

Sedation in endoscopy is a drug-induced depression in the level of consciousness. Traditionally, the sedation regime most commonly used for conscious sedation during gastrointestinal (GI) endoscopy was a combination of opioids and benzodiazepines. However, in the last two decades, propofol is regarded as the sine qua non agent for gastroenterological endoscopic sedation. A thorough risk evaluation before the procedure and monitoring during the procedure are paramount. In elective endoscopy, unplanned adverse events are rare, occurring in 1.4% of procedures. All currently available guidelines state that the endoscopist is not permitted to administer propofol and to monitor the patient. This task must be done by an additional person, who has the sole responsibility of administering the sedative and monitoring the patient. Various scoring systems exist for defining the discharge criteria, of which the Aldrete score is the most commonly used.

 
  • References

  • 1 Goudra B. Big sleep: beyond propofol sedation during GI endoscopy. Dig Dis Sci 2019; 64 (01) 1-3
  • 2 Riphaus A, Wehrmann T, Hausmann J. et al. Update S3-guideline: “sedation for gastrointestinal endoscopy” 2014 (AWMF-register-no. 021/014). Z Gastroenterol 2016; 54 (01) 58-95
  • 3 Zuckerman MJ, Shen B, Harrison III ME. Standards of Practice Committee. et al. Informed consent for GI endoscopy. Gastrointest Endosc 2007; 66 (02) 213-218
  • 4 American Society of Anesthesiologists Committee. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: an updated report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2011; 114 (03) 495-511
  • 5 Early DS, Lightdale JR, Vargo II JJ. ASGE Standards of Practice Committee. et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2018; 87 (02) 327-337
  • 6 Miller MA, Levy P, Patel MM. Procedural sedation and analgesia in the emergency department: what are the risks?. Emerg Med Clin North Am 2005; 23 (02) 551-572
  • 7 Qureshi WA, Rajan E, Adler DG. et al; American Society for Gastrointestinal Endoscopy. ASGE Guideline: Guidelines for endoscopy in pregnant and lactating women. Gastrointest Endosc 2005; 61 (03) 357-362
  • 8 Vargo JJ. Minimizing complications: sedation and monitoring. Gastrointest Endosc Clin N Am 2007; 17 (01) 11-28 , v–vi
  • 9 Sharma VK, Nguyen CC, Crowell MD, Lieberman DA, de Garmo P, Fleischer DE. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 2007; 66 (01) 27-34
  • 10 Cohen LB, Delegge MH, Aisenberg J. et al; AGA Institute. AGA Institute review of endoscopic sedation. Gastroenterology 2007; 133 (02) 675-701
  • 11 Lichtenstein DR, Jagannath S, Baron TH. et al; Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. Sedation and anesthesia in GI endoscopy. Gastrointest Endosc 2008; 68 (05) 815-826
  • 12 Christe C, Janssens JP, Armenian B, Herrmann F, Vogt N. Midazolam sedation for upper gastrointestinal endoscopy in older persons: a randomized, double-blind, placebo-controlled study. J Am Geriatr Soc 2000; 48 (11) 1398-1403
  • 13 Müller M, Wehrmann T. How best to approach endoscopic sedation?. Nat Rev Gastroenterol Hepatol 2011; 8 (09) 481-490
  • 14 Amorós A, Aparicio JR, Garmendia M, Casellas JA, Martínez J, Jover R. Deep sedation with propofol does not precipitate hepatic encephalopathy during elective upper endoscopy. Gastrointest Endosc 2009; 70 (02) 262-268
  • 15 Bamji N, Cohen LB. Endoscopic sedation of patients with chronic liver disease. Clin Liver Dis 2010; 14 (02) 185-194
  • 16 Rex DK, Deenadayalu VP, Eid E. et al. Endoscopist-directed administration of propofol: a world wide safety experience. Gastroenterology 2009; 137 (04) 1229-1237 , quiz 1518–1519
  • 17 American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002; 96 (04) 1004-1017
  • 18 Heneghan S, Myers J, Fanelli R, Richardson W. Society of American Gastrointestinal Endoscopic Surgeons. Society of American Gastrointestinal Endoscopic Surgeons (SAGES) guidelines for office endoscopic services. Surg Endosc 2009; 23 (05) 1125-1129
  • 19 Newman DH, Azer MM, Pitetti RD, Singh S. When is a patient safe for discharge after procedural sedation?. The timing of adverse effect events in 1367 pediatric procedural sedations. Ann Emerg Med 2003; 42 (05) 627-635
  • 20 Aldrete JA. Modifications to the postanesthesia score for use in ambulatory surgery. J Perianesth Nurs 1998; 13 (03) 148-155
  • 21 Vargo JJ. Doc, can I drive home?. Am J Gastroenterol 2009; 104 (07) 1656-1657